From the miRoncol archive: This historical update may contain promotional language or research findings that do not describe the current service. Retrospective research results do not establish prospective screening performance, and references to scientific prizes do not imply evaluation or endorsement of miRoncol or miCheckup. Do not rely on this archive for healthcare decisions; use the current product information and discuss screening decisions with a healthcare professional.
miRoncol established a Business Advisory Board in April 2024 to provide strategic guidance as the company developed its research and commercialization plans.
The announced board members included:
- Beth Rogozinski, CEO, Oncoustics
- Jiah Pearson-Leary, PhD, CEO, Spire Bio Advisory
- Vinona Bhatia, MD, MPH, Principal, Atapir
Advisory-board participation does not constitute regulatory approval or a guarantee of product performance or clinical outcomes.